Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...

Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...

Small-caps often see upward moves around the presidential election. A Trump win would boost the sector even further, Cantor ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...

Cantor Fitzgerald reiterated their neutral rating on shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) in a ...

In a report released yesterday, Sarah James from Cantor Fitzgerald maintained a Buy rating on UnitedHealth (UNH – Research Report), with ...

Companies are investing heavily in AI infrastructure to meet the growing demands of machine learning, data processing, and AI ...

On Tuesday, Cantor Fitzgerald began covering LeMaitre Vascular (NASDAQ:LMAT), a company specializing in medical devices and services for peripheral vascular disease treatment, with a Neutral ...

NEW YORK, Oct. 15, 2024 /PRNewswire/ -- Cantor Fitzgerald Infrastructure Fund (the "Fund") today announced a third-quarter distribution of $0.1170 per Class A share (NASDAQ: CAFIX), $0.1156 per ...

Cantor Fitzgerald International Eq Fund earns an Above Average Process Pillar rating. The most meaningful contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 100%.

On Tuesday, Cantor Fitzgerald began covering LeMaitre Vascular (NASDAQ:LMAT), a company specializing in medical devices and services for peripheral vascular disease treatment, with a Neutral rating ...